Matwall: materials knowledge transfer from early phase development to commercial launch of new medicines

Pharmaceutical industry experts Rob Willacy (CCDC) and Simon Black (Sycryst) discuss the five levels of the Matwall framework to support effective knowledge transfer throughout the drug development process.

You will learn:

  • How crystal structures are fundamental to robust regulatory submissions and manufacturing processes
  • Real-world example of a materials-based risk assessment of an active pharmaceutical ingredient through commercial process development

Who should watch;

  • Solid form scientists
  • Pharmaceutical development scientists
  • Team Leaders in drug development

Watch On-Demand